The Effect of Rectal & Sublingual Misoprostol NCT01931410

Updated 05/17/2024

Clinical Trial Details — Status: Completed

Administrative data
NCT number	NCT01931410
Other study ID #	Asicioglu-05
Secondary ID
Status	Completed
Phase	Phase 4
First received	August 26, 2013
Last updated	February 24, 2014
Start date	June 2013
Est. completion date	February 2014

Study information
Verified date	February 2014
Source	Istanbul Bakirkoy Maternity and Children Diseases Hospital
Contact	n/a
Is FDA regulated	No
Health authority
Study type	Interventional

Clinical Trial Summary

The investigators hypothesis in this study is that administration of rectal and sublingual misoprostol decreases intrapartum and postpartum haemorrhage.

Recruitment information / eligibility
Status	Completed
Enrollment	618
Est. completion date	February 2014
Est. primary completion date	January 2014
Accepts healthy volunteers	No
Gender	Female
Age group	18 Years to 44 Years
Eligibility	Inclusion Criteria: 1. live and singleton pregnancy 2. Elective caesarean 3. Gestational week greater than 37 weeks 4. patient between 18-44 year old Exclusion Criteria: 1. -multiple pregnancy 2. Preeclampsia 3. Gestational diabetes 4. Macrosomia 5. Oligohidraamnios 6. Polihidraamnios 7. Myoma 8. Morbid obesity 9. Coagulation defect (such as HELLP syndrome)

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Misoprostol

Locations
Country	Name	City	State
n/a

Sponsors *(1)*
Lead Sponsor	Collaborator
Istanbul Bakirkoy Maternity and Children Diseases Hospital

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Postpartum Haemorrhage		postpartum 24 hour

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02509351` - Could Pre-operative Rectal Misoprostol Reduce Intra-operative Blood Loss During Ceserean Section?	Phase 2/Phase 3
	Completed	`NCT01931423` - The Influence of Placental Drainage of Management of the Third Stage of Labor:a Randomized Controlled Study	N/A
	Completed	`NCT00499005` - Carbetocin Versus Syntometrine for the Third Stage of Labour	Phase 4
	Completed	`NCT01485562` - Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home Births	N/A
	Completed	`NCT01359878` - Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial	Phase 2/Phase 3
	Completed	`NCT00872469` - World Maternal Antifibrinolytic Trial	Phase 3
	Completed	`NCT02704780` - Two Different Regimens of Misoprostol in Retained Placenta	Phase 2
	Not yet recruiting	`NCT02396303` - Carbetocin Versus Oxytocin in Caesarean Section for the Control of Postpartum Haemorrhage	Phase 0
	Completed	`NCT01895218` - Treatment of Women After Postpartum Haemorrhage	Phase 3
	Recruiting	`NCT02187874` - Timing of Umbilical Cord Occlusion in Premature Babies( <33 w). Delayed vs Early.	N/A
	Withdrawn	`NCT01910675` - PCC and Fibrinogen Compared With FFP in PPH	Phase 4
	Completed	`NCT02562300` - Uterotonics Using to Reduce Bleeding at Cesarean Section	Phase 2
	Completed	`NCT01044082` - Prevention of Post-partum Haemorrhage	N/A
	Completed	`NCT01116050` - Intrarectal Misoprostol in Postpartum Haemorrhage	Phase 3
	Completed	`NCT02149472` - Towards Better Prognostic and Diagnostic Strategies for Haemostatic Changes During Major Obstetric Haemorrhage
	Recruiting	`NCT02492087` - Topical Tranexamic Acid in Caesarean Section	Phase 3
	Completed	`NCT02468310` - Evaluating the Effects of SMS Text Messaging Support System Among Frontline Health Workers in Ghana	N/A
	Recruiting	`NCT02136719` - Bimanual Uterine Compression to Reduce Blood Loss and Prevent Postpartum Haemorrhage After Vaginal Delivery	N/A